Red Flags Detected
- Goodwill Impairment (new) — Additional $0.3M MTEX goodwill impairment in fiscal 2026 follows $13.4M charge in fiscal 2025, totaling $13.7M cumulative impairment on the May 2024 acquisition.
- Material Weakness (removed) — Prior-year material weakness related to Astro Machine subsidiary controls was remediated as of January 31, 2025 and no longer disclosed.
AstroNova explores strategic alternatives amid CEO turnover, workforce cuts, and MTEX struggles
Filed April 15, 2026 · Period ending January 31, 2026 · Compared to 10-K Apr 15, 2025 · ~1 min read
Key Changes
-
high
Board announced April 7, 2026 review of strategic alternatives including potential sale, merger, or business combination to maximize shareholder value.
Business: Strategic Alternatives Review verify on EDGAR → -
high
Complete CEO transition: Gregory Woods replaced by Jorik Ittmann in August 2025; company disclosed high senior management turnover during fiscal 2026.
Business: Executive Leadership & Risk Factors verify on EDGAR → -
high
Headcount reduced by 43 employees (10%) to 398, concentrated in U.S. and Europe, despite MTEX adding 72 employees prior year; restructuring targets $3.0M annualized savings.
Business & MD&A: Restructuring verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.
Partner
Trade ALOT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 11, 2026 12:59 AM